Chemomab Therapeutics Ltd

$3.63 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Chemomab Therapeutics Ltd

Chemomab Therapeutics Ltd, formerly known as Anchiano Therapeutics Ltd, is a Israel-based biopharmaceutical company. The Company specializes in the development of patient oriented targeted therapy for the treatment of a wide range of cancers. Its therapeutic and diagnostic technology, BC-819, constitutes a search paradigm for the targeted destruction of cancer cells with no effect on surrounding tissue and no observed side effects for long-term, safe treatment and prevention of cancer. The patient oriented targeted therapy approach is based on the identification of particular genes that are expressed only in tumors.

Stock Analysis

last close $3.5
1-mo return 1.2%
3-mo return 24.1%
avg daily vol. 35.31T
52-week high 17.39
52-week low 2.53
market cap. $40M
forward pe -
annual div. -
roe -28.3%
ltg forecast -
dividend yield -
annual rev. $--
inst own. 35.5%

Subscribe now for daily local and international financial news